ask="23.19"
ask_size="600"
average_daily_volume="429918"
bid="20.91"
bid_size="400"
book_value="3.21"
change="+1.02"
change_from_200_day_moving_average="6.13"
change_from_50_day_moving_average="1.00"
change_from_52_week_high="-2.64"
change_From_52_week_low="15.25"
change_in_percent="+5.08%"
close="21.11"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.48"
ex_dividend_date="N/A"
float_shares="7150000"
high="21.60"
high_52_weeks="23.75"
last_trade_date="3/8/2017"
last_trade_price="21.11"
last_trade_size="2063"
last_trade_time="4:00pm"
low="20.07"
low_52_weeks="5.86"
market_capitalization="210.11M"
moving_average_200_day="14.98"
moving_average_50_day="20.11"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.63"
open="20.07"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+40.95%"
percent_change_from_50_day_moving_average="+4.99%"
percent_change_from_52_week_high="-11.12%"
percent_change_from_52_week_low="+260.24%"
previous_close="20.09"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.26"
price_per_sales="3537.54"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="3.00"
stock_exchange="NGM"
symbol="ZYNE"
volume="276003"
weeks_range_52="5.86 - 23.75"
